MANNKIND CORP Variable Lease, Cost
MANNKIND CORP (MNKD) reported Variable Lease, Cost of $108.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-05
- MANNKIND CORP variable lease, cost for the quarter ending 2026-06-30 was $108.00K, a 42.86% decline year-over-year.
- MANNKIND CORP variable lease, cost for the quarter ending 2026-03-31 was $147.00K, a 39.75% decline year-over-year.
- MANNKIND CORP variable lease, cost for the quarter ending 2025-12-31 was $156.00K, a 39.29% increase year-over-year.
- MANNKIND CORP variable lease, cost for the quarter ending 2025-09-30 was $199.00K, a 91.35% increase year-over-year.
- MANNKIND CORP variable lease, cost for fiscal 2025 was $787.00K, a 236.32% increase from fiscal 2024.
- MANNKIND CORP variable lease, cost for fiscal 2024 was $234.00K, a 125.00% increase from fiscal 2023.
- MANNKIND CORP variable lease, cost for fiscal 2023 was $104.00K, a 62.04% decline from fiscal 2022.
- MANNKIND CORP variable lease, cost for fiscal 2022 was $274.00K, a 0.00% change from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $108.00K 10-Q · filed 2026-08-05 | $256.00K 10-Q · filed 2026-08-05 | $411.00K derived: sum of 3 quarters · filed 2026-08-05 | $610.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $147.00K 10-Q · filed 2026-05-06 | $303.00K derived: sum of 2 quarters · filed 2026-05-06 | $502.00K derived: sum of 3 quarters · filed 2026-05-06 | $691.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $355.00K derived: sum of 2 quarters · filed 2026-02-26 | $544.00K derived: sum of 3 quarters · filed 2026-08-05 | $787.00K 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $199.00K 10-Q · filed 2025-11-05 | $388.00K derived: sum of 2 quarters · filed 2026-08-05 | $631.00K 10-Q · filed 2025-11-05 | $744.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $189.00K 10-Q · filed 2026-08-05 | $432.00K 10-Q · filed 2026-08-05 | $545.00K derived: sum of 3 quarters · filed 2026-08-05 | $649.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $244.00K 10-Q · filed 2026-05-06 | $356.00K derived: sum of 2 quarters · filed 2026-05-06 | $460.00K derived: sum of 3 quarters · filed 2026-05-06 | $469.00K derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $216.00K derived: sum of 2 quarters · filed 2026-02-26 | $225.00K derived: sum of 3 quarters · filed 2026-02-26 | $234.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $104.00K 10-Q · filed 2025-11-05 | $113.00K derived: sum of 2 quarters · filed 2025-11-05 | $122.00K 10-Q · filed 2025-11-05 | $130.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $9.00K 10-Q · filed 2025-08-06 | $19.00K 10-Q · filed 2025-08-06 | $26.00K derived: sum of 3 quarters · filed 2026-02-26 | $74.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $10.00K 10-Q · filed 2025-05-08 | $17.00K derived: sum of 2 quarters · filed 2026-02-26 | $65.00K derived: sum of 3 quarters · filed 2026-02-26 | $78.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $55.00K derived: sum of 2 quarters · filed 2026-02-26 | $68.00K derived: sum of 3 quarters · filed 2026-02-26 | $104.00K 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $48.00K 10-Q · filed 2024-11-07 | $61.00K derived: sum of 2 quarters · filed 2024-11-07 | $97.00K 10-Q · filed 2024-11-07 | $136.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $13.00K 10-Q · filed 2024-08-07 | $49.00K 10-Q · filed 2024-08-07 | $88.00K derived: sum of 3 quarters · filed 2024-08-07 | $164.00K derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $36.00K 10-Q · filed 2024-05-08 | $75.00K derived: sum of 2 quarters · filed 2024-05-08 | $151.00K derived: sum of 3 quarters · filed 2024-05-08 | $224.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $115.00K derived: sum of 2 quarters · filed 2024-02-27 | $188.00K derived: sum of 3 quarters · filed 2024-02-27 | $274.00K 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | $76.00K 10-Q · filed 2023-11-07 | $149.00K derived: sum of 2 quarters · filed 2023-11-07 | $235.00K 10-Q · filed 2023-11-07 | $150.00K derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-07 | $159.00K 10-Q · filed 2023-08-07 | $74.00K derived: sum of 3 quarters · filed 2025-02-26 | $202.00K derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-03-31 | $86.00K 10-Q · filed 2023-05-09 | $1.00K derived: sum of 2 quarters · filed 2025-02-26 | $129.00K derived: sum of 3 quarters · filed 2025-02-26 | $243.00K derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2021-12-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $43.00K derived: sum of 2 quarters · filed 2025-02-26 | $157.00K derived: sum of 3 quarters · filed 2025-02-26 | $274.00K 10-K · filed 2025-02-26 | $515.00K 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $128.00K 10-Q · filed 2022-11-08 | $242.00K derived: sum of 2 quarters · filed 2022-11-08 | $359.00K 10-Q · filed 2022-11-08 | $451.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $114.00K 10-Q · filed 2022-08-09 | $231.00K 10-Q · filed 2022-08-09 | $323.00K derived: sum of 3 quarters · filed 2023-02-23 | $439.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $111.00K 10-Q · filed 2022-05-05 | $111.20K 10-Q · filed 2021-05-12 | $209.00K derived: sum of 2 quarters · filed 2023-02-23 | $325.00K derived: sum of 3 quarters · filed 2023-02-23 | $404.00K derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $214.00K derived: sum of 2 quarters · filed 2023-02-23 | $293.00K derived: sum of 3 quarters · filed 2023-02-23 | $394.00K 10-K · filed 2023-02-23 | $400.00K 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $116.00K 10-Q · filed 2021-11-09 | $100.00K 10-Q · filed 2020-11-04 | $195.00K derived: sum of 2 quarters · filed 2021-11-09 | $296.00K 10-Q · filed 2021-11-09 | $300.00K 10-Q · filed 2020-11-04 | $395.50K derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $79.00K 10-Q · filed 2021-08-11 | $100.00K 10-Q · filed 2020-08-05 | $180.00K 10-Q · filed 2021-08-11 | $200.00K 10-Q · filed 2020-08-05 | $279.50K derived: sum of 3 quarters · filed 2021-08-11 | $379.50K derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $100.50K 10-Q · filed 2021-05-12 | $100.00K 10-Q · filed 2020-05-06 | $200.50K derived: sum of 2 quarters · filed 2021-05-12 | $300.50K derived: sum of 3 quarters · filed 2021-05-12 | $400.50K derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $200.00K derived: sum of 2 quarters · filed 2021-02-25 | $300.00K derived: sum of 3 quarters · filed 2021-02-25 | $400.00K 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-04 | $200.00K derived: sum of 2 quarters · filed 2020-11-04 | $300.00K 10-Q · filed 2020-11-04 | |||||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-05 | $200.00K 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | $100.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |